These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1283389)

  • 1. New angiogenesis inhibitors, WF-16775 A1 and A2.
    Otsuka T; Takase S; Terano H; Okuhara M
    J Antibiot (Tokyo); 1992 Dec; 45(12):1970-3. PubMed ID: 1283389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor necrotic factor as an inhibitor of angiogenesis].
    Sopotsinskaia EB; Lisniak IA
    Patol Fiziol Eksp Ter; 1988; (5):62-4. PubMed ID: 2464155
    [No Abstract]   [Full Text] [Related]  

  • 3. A new angiogenesis inhibitor, FR-111142.
    Otsuka T; Shibata T; Tsurumi Y; Takase S; Okuhara M; Terano H; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1992 Mar; 45(3):348-54. PubMed ID: 1374374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis by anthracyclines and titanocene dichloride.
    Maragoudakis ME; Peristeris P; Missirlis E; Aletras A; Andriopoulou P; Haralabopoulos G
    Ann N Y Acad Sci; 1994 Sep; 732():280-93. PubMed ID: 7526759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.
    Wild R; Dhanabal M; Olson TA; Ramakrishnan S
    Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an inhibitor of neovascularization from cartilage.
    Moses MA; Sudhalter J; Langer R
    Science; 1990 Jun; 248(4961):1408-10. PubMed ID: 1694043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenesis as a new concept for the therapy of neovascular diseases.
    Schweigerer L
    Klin Wochenschr; 1991 Jul; 69(10):417-8. PubMed ID: 1719269
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    BenEzra D
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2433-4. PubMed ID: 9375559
    [No Abstract]   [Full Text] [Related]  

  • 9. Kobutimycins A and B, new alkaloid antibiotics produced by a Streptomyces strain.
    Kanbe K; Naganawa H; Okami Y; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1700-2. PubMed ID: 1474001
    [No Abstract]   [Full Text] [Related]  

  • 10. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis.
    Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH
    Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant.
    Lemus D; Dabancens A; Illanes J; Fuenzalida M; Guerrero A; López C
    Biol Res; 2001; 34(3-4):227-36. PubMed ID: 11715860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
    Ziche M; Maglione D; Ribatti D; Morbidelli L; Lago CT; Battisti M; Paoletti I; Barra A; Tucci M; Parise G; Vincenti V; Granger HJ; Viglietto G; Persico MG
    Lab Invest; 1997 Apr; 76(4):517-31. PubMed ID: 9111514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2.
    Sakkoula E; Pipili-Synetos E; Maragoudakis ME
    Br J Pharmacol; 1997 Nov; 122(5):793-5. PubMed ID: 9384490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?
    Gasparini G; Harris AL
    Eur J Cancer; 1994; 30A(2):201-6. PubMed ID: 7512357
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells.
    Watanabe J; Endo Y; Shimada N; Natsume T; Sasaki T; Kobayashi M
    In Vivo; 2007; 21(2):297-304. PubMed ID: 17436580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAN-1323 C and D, new concanamycin-group antibiotics; detection of the angiostatic activity with a wide range of macrolide antibiotics.
    Ishii T; Hida T; Iinuma S; Muroi M; Nozaki Y
    J Antibiot (Tokyo); 1995 Jan; 48(1):12-20. PubMed ID: 7532643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.
    Oka M; Iimura S; Tenmyo O; Sawada Y; Sugawara M; Ohkusa N; Yamamoto H; Kawano K; Hu SL; Fukagawa Y
    J Antibiot (Tokyo); 1993 Mar; 46(3):367-73. PubMed ID: 8478254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New piericidin antibiotics, 7-demethylpiericidin A1 and 7-demethyl-3'-rhamnopiericidin A1.
    Kimura K; Takahashi H; Miyata N; Yoshihama M; Uramoto M
    J Antibiot (Tokyo); 1996 Jul; 49(7):697-9. PubMed ID: 8784434
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
    Oikawa T; Sasaki M; Inose M; Shimamura M; Kuboki H; Hirano S; Kumagai H; Ishizuka M; Takeuchi T
    Anticancer Res; 1997; 17(3C):1881-6. PubMed ID: 9216639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.